Table 3.

ABCG2 mRNA expression in plasma cells from subjects enrolled in the MTV trial




ABCG2 mRNA expression/cell*

Paired sample
n
Before HDC
During HDC
Relapse from HDC
P
Before HDC versus during HDC      
    Dose level 1   6   29.3   48.2   NA   .56  
    Dose levels 2 to 5   20   118.4   232.5   NA   .033  
Before HDC versus relapsed from HDC      
    Dose level 1   5   26.6   NA   17.6   .999  
    Dose levels 2 to 5
 
11
 
31.7
 
NA
 
117.1
 
.001
 



ABCG2 mRNA expression/cell*

Paired sample
n
Before HDC
During HDC
Relapse from HDC
P
Before HDC versus during HDC      
    Dose level 1   6   29.3   48.2   NA   .56  
    Dose levels 2 to 5   20   118.4   232.5   NA   .033  
Before HDC versus relapsed from HDC      
    Dose level 1   5   26.6   NA   17.6   .999  
    Dose levels 2 to 5
 
11
 
31.7
 
NA
 
117.1
 
.001
 

The analyses presented are for paired samples only, that is, before + during and before + relapse.

NA indicates not applicable.

*

The expression of ABCG2 is normalized to that of GAPDH.

Wilcoxon signed rank test.

or Create an Account

Close Modal
Close Modal